Assetmark Inc. increased its holdings in shares of iShares Silver Trust (NYSEARCA:SLV – Free Report) by 5.2% in the fourth ...
GigaGen, a subsidiary of Grifols, has commenced a Phase I dose escalation trial, with the first patient receiving a dose of GIGA-2339, a recombinant polyclonal drug candidate aimed at treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback